Related Experiment Video
Updated: May 30, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Maxillary MRSA osteomyelitis in a paediatric patient: non-surgical management
Deepti Vepakomma1, Shikha Yadav2
1Paediatric Surgery, All India Institute of Medical Sciences Mangalagiri, Mangalagiri, Andhra Pradesh, India.
None:
Methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis of the maxilla is a rare condition in paediatric patients, with limited evidence available for optimal treatment protocols. We present the case of a paediatric patient in the early childhood age group with post-traumatic maxillary osteomyelitis caused by MRSA. The child developed facial swelling following trauma, and imaging revealed maxillary sinus wall thickening and bone erosions. After initial treatment with analgesics, the swelling persisted, leading to surgical intervention and microbiological analysis confirming MRSA infection. The patient was treated with intravenous linezolid and amikacin for 5 days, followed by 8 weeks of oral linezolid. One year post-treatment, the child remained healthy with no recurrence. This case highlights the importance of early diagnosis, tailored antibiotic therapy and conservative surgical management to ensure positive outcomes in paediatric maxillary osteomyelitis cases. Further research is needed to establish standardised treatment protocols for facial osteomyelitis in children.
Related Concept Videos
Tonsillitis II: Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

